SPP1 mRNA determination based on molecular beacon for the recurrence prognosis of bladder cancer.

"Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tau.amegroups.com/article/view/10.21037/tau-23-432/coif). Z.X. is serving as an executive editor and editorial board member of Translational Andrology and Urology from March 2022 to February 2024. The other authors have no conflicts of interest to declare."

"Funding: This study was supported by the Tianjin Municipal Health Industry Key Project ( No. TJWJ2022XK014 ), the Scientific Research Project of Tianjin Municipal Education Commission ( No. 2022ZD069 ), the Youth Fund of the Second Hospital of Tianjin Medical University ( No. 2022ydey15 ), and the Talents Cultivated Project of Department of Urology, the Second Hospital of Tianjin Medical University ( No. MNRC202313 )."